Successful treatment of congenital chylous ascites with a somatostatin analogue

Pediatr Surg Int. 1996 Jun;11(5-6):396-7. doi: 10.1007/BF00497824. Epub 2013 Sep 21.

Abstract

Congenital chylous ascites (CCA) results from maldevelopment of the intra-abdominal lymphatic system. Newborns present with respiratory distress and abdominal distention. Medical treatment of CCA is often prolonged. A newborn with CCA was treated with octreotide, a somatostatin analogue, resulting in rapid and complete resolution of the ascites.